Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Signaling: cellular insights into the pathophysiology of bipolar disorder.

Manji HK, Lenox RH.

Biol Psychiatry. 2000 Sep 15;48(6):518-30. Review.

PMID:
11018224
2.
3.

Neurobiology of lithium: an update.

Lenox RH, McNamara RK, Papke RL, Manji HK.

J Clin Psychiatry. 1998;59 Suppl 6:37-47. Review.

4.

Overview of the mechanism of action of lithium in the brain: fifty-year update.

Lenox RH, Hahn CG.

J Clin Psychiatry. 2000;61 Suppl 9:5-15. Review.

5.

The nature of bipolar disorder.

Manji HK, Lenox RH.

J Clin Psychiatry. 2000;61 Supp 13:42-57. Review.

6.

Signal transduction pathways. Molecular targets for lithium's actions.

Manji HK, Potter WZ, Lenox RH.

Arch Gen Psychiatry. 1995 Jul;52(7):531-43. Review.

PMID:
7598629
7.

Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders.

Manji HK, Chen G.

Curr Psychiatry Rep. 2000 Dec;2(6):479-89. Review.

PMID:
11122999
8.

Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.

Hahn CG, Friedman E.

Bipolar Disord. 1999 Dec;1(2):81-6. Review.

PMID:
11252663
9.

[Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].

Einat H, Chen G, Manji H.

Harefuah. 2004 Jun;143(6):420-5, 462. Review. Hebrew.

PMID:
15524099
11.

Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.

Quiroz JA, Singh J, Gould TD, Denicoff KD, Zarate CA, Manji HK.

Mol Psychiatry. 2004 Aug;9(8):756-76. Review.

PMID:
15136795
12.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
13.

Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium.

Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT.

Brain Res Bull. 2001 Jul 15;55(5):625-9.

PMID:
11576759
14.

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.

Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK.

Mol Psychiatry. 2004 Aug;9(8):734-55. Review.

PMID:
15136794
15.
16.

[Physiopathology of bipolar disorders: what have changed in the last 10 years?].

Kapczinski F, Frey BN, Zannatto V.

Rev Bras Psiquiatr. 2004 Oct;26 Suppl 3:17-21. Epub 2004 Dec 7. Review. Portuguese.

17.

[Neuropatological and neurochemical abnormalities in bipolar disorder].

Frey BN, Fonseca MM, Machado-Vieira R, Soares JC, Kapczinski F.

Rev Bras Psiquiatr. 2004 Sep;26(3):180-8. Epub 2004 Nov 17. Review. Portuguese.

18.

Neurobiology of bipolar illness: implications for future study and therapeutics.

Post RM, Speer AM, Hough CJ, Xing G.

Ann Clin Psychiatry. 2003 Jun;15(2):85-94. Review.

PMID:
12938866
19.

A molecular model for bipolar affective disorder.

Lachman HM, Papolos DF.

Med Hypotheses. 1995 Sep;45(3):255-64.

PMID:
8569548
20.

Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.

Soeiro-de-Souza MG, Dias VV, Figueira ML, Forlenza OV, Gattaz WF, Zarate CA Jr, Machado-Vieira R.

Acta Psychiatr Scand. 2012 Nov;126(5):332-41. doi: 10.1111/j.1600-0447.2012.01889.x. Epub 2012 Jun 8. Review.

Items per page

Supplemental Content

Write to the Help Desk